Fig. 2From: High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatinProgression-free survival (2a) and overall survival (2b) of all patientsBack to article page